GlaxoSmithKline Admits To Huge Drug Fraud

July 12, 2012

Jennifer Johnson reports the Justice Department says GlaxoSmithKline will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to report important safety data about a diabetes drug to the Food and Drug Administration.

comments powered by Disqus